nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Pruritus—Pemetrexed—lung cancer	0.00307	0.00307	CcSEcCtD
Ceftizoxime—Pruritus—Gefitinib—lung cancer	0.00305	0.00305	CcSEcCtD
Ceftizoxime—Anaemia—Vinblastine—lung cancer	0.00304	0.00304	CcSEcCtD
Ceftizoxime—Neutropenia—Irinotecan—lung cancer	0.00302	0.00302	CcSEcCtD
Ceftizoxime—Vomiting—Crizotinib—lung cancer	0.00302	0.00302	CcSEcCtD
Ceftizoxime—Phlebitis—Docetaxel—lung cancer	0.003	0.003	CcSEcCtD
Ceftizoxime—Rash—Crizotinib—lung cancer	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Dermatitis—Crizotinib—lung cancer	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Pancytopenia—Gemcitabine—lung cancer	0.00299	0.00299	CcSEcCtD
Ceftizoxime—Diarrhoea—Pemetrexed—lung cancer	0.00297	0.00297	CcSEcCtD
Ceftizoxime—Anaemia—Topotecan—lung cancer	0.00295	0.00295	CcSEcCtD
Ceftizoxime—Diarrhoea—Gefitinib—lung cancer	0.00295	0.00295	CcSEcCtD
Ceftizoxime—Neutropenia—Gemcitabine—lung cancer	0.00294	0.00294	CcSEcCtD
Ceftizoxime—Leukopenia—Vinblastine—lung cancer	0.00294	0.00294	CcSEcCtD
Ceftizoxime—Leukopenia—Topotecan—lung cancer	0.00286	0.00286	CcSEcCtD
Ceftizoxime—Convulsion—Vinblastine—lung cancer	0.00285	0.00285	CcSEcCtD
Ceftizoxime—Nausea—Crizotinib—lung cancer	0.00282	0.00282	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Etoposide—lung cancer	0.0028	0.0028	CcSEcCtD
Ceftizoxime—Pancytopenia—Cisplatin—lung cancer	0.00279	0.00279	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.00278	0.00278	CcSEcCtD
Ceftizoxime—Body temperature increased—Teniposide—lung cancer	0.00278	0.00278	CcSEcCtD
Ceftizoxime—Vomiting—Pemetrexed—lung cancer	0.00276	0.00276	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Paclitaxel—lung cancer	0.00275	0.00275	CcSEcCtD
Ceftizoxime—Vomiting—Gefitinib—lung cancer	0.00274	0.00274	CcSEcCtD
Ceftizoxime—Rash—Pemetrexed—lung cancer	0.00274	0.00274	CcSEcCtD
Ceftizoxime—Dermatitis—Pemetrexed—lung cancer	0.00273	0.00273	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—lung cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Rash—Gefitinib—lung cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Dermatitis—Gefitinib—lung cancer	0.00272	0.00272	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vinblastine—lung cancer	0.00263	0.00263	CcSEcCtD
Ceftizoxime—Agranulocytosis—Gemcitabine—lung cancer	0.00262	0.00262	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Topotecan—lung cancer	0.00261	0.00261	CcSEcCtD
Ceftizoxime—Haemoglobin—Irinotecan—lung cancer	0.0026	0.0026	CcSEcCtD
Ceftizoxime—Hypersensitivity—Teniposide—lung cancer	0.00259	0.00259	CcSEcCtD
Ceftizoxime—Haemorrhage—Irinotecan—lung cancer	0.00259	0.00259	CcSEcCtD
Ceftizoxime—Nausea—Pemetrexed—lung cancer	0.00258	0.00258	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Methotrexate—lung cancer	0.00257	0.00257	CcSEcCtD
Ceftizoxime—Nausea—Gefitinib—lung cancer	0.00256	0.00256	CcSEcCtD
Ceftizoxime—Pancytopenia—Etoposide—lung cancer	0.00255	0.00255	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Topotecan—lung cancer	0.00255	0.00255	CcSEcCtD
Ceftizoxime—Haemoglobin—Gemcitabine—lung cancer	0.00253	0.00253	CcSEcCtD
Ceftizoxime—Anaemia—Vinorelbine—lung cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Erlotinib—lung cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Haemorrhage—Gemcitabine—lung cancer	0.00252	0.00252	CcSEcCtD
Ceftizoxime—Neutropenia—Etoposide—lung cancer	0.00251	0.00251	CcSEcCtD
Ceftizoxime—Pancytopenia—Paclitaxel—lung cancer	0.0025	0.0025	CcSEcCtD
Ceftizoxime—Pruritus—Teniposide—lung cancer	0.00249	0.00249	CcSEcCtD
Ceftizoxime—Neutropenia—Paclitaxel—lung cancer	0.00246	0.00246	CcSEcCtD
Ceftizoxime—Leukopenia—Vinorelbine—lung cancer	0.00244	0.00244	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—lung cancer	0.00244	0.00244	CcSEcCtD
Ceftizoxime—Vaginal infection—Methotrexate—lung cancer	0.00242	0.00242	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Methotrexate—lung cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Paraesthesia—Vinblastine—lung cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Diarrhoea—Teniposide—lung cancer	0.0024	0.0024	CcSEcCtD
Ceftizoxime—Erythema multiforme—Gemcitabine—lung cancer	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Etoposide—lung cancer	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Paraesthesia—Topotecan—lung cancer	0.00234	0.00234	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Docetaxel—lung cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Pain—Vinblastine—lung cancer	0.00229	0.00229	CcSEcCtD
Ceftizoxime—Agranulocytosis—Etoposide—lung cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Vomiting—Teniposide—lung cancer	0.00223	0.00223	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Vinorelbine—lung cancer	0.00223	0.00223	CcSEcCtD
Ceftizoxime—Pain—Topotecan—lung cancer	0.00223	0.00223	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—lung cancer	0.00222	0.00222	CcSEcCtD
Ceftizoxime—Rash—Teniposide—lung cancer	0.00222	0.00222	CcSEcCtD
Ceftizoxime—Dermatitis—Teniposide—lung cancer	0.00221	0.00221	CcSEcCtD
Ceftizoxime—Pain—Erlotinib—lung cancer	0.0022	0.0022	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Vinorelbine—lung cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Etoposide—lung cancer	0.00214	0.00214	CcSEcCtD
Ceftizoxime—Pancytopenia—Docetaxel—lung cancer	0.00212	0.00212	CcSEcCtD
Ceftizoxime—Haemoglobin—Paclitaxel—lung cancer	0.00212	0.00212	CcSEcCtD
Ceftizoxime—Haemorrhage—Paclitaxel—lung cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Paclitaxel—lung cancer	0.0021	0.0021	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—lung cancer	0.0021	0.0021	CcSEcCtD
Ceftizoxime—Neutropenia—Docetaxel—lung cancer	0.00209	0.00209	CcSEcCtD
Ceftizoxime—Nausea—Teniposide—lung cancer	0.00209	0.00209	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—lung cancer	0.00209	0.00209	CcSEcCtD
Ceftizoxime—Anaemia—Irinotecan—lung cancer	0.00208	0.00208	CcSEcCtD
Ceftizoxime—Body temperature increased—Topotecan—lung cancer	0.00206	0.00206	CcSEcCtD
Ceftizoxime—Body temperature increased—Erlotinib—lung cancer	0.00204	0.00204	CcSEcCtD
Ceftizoxime—Erythema multiforme—Etoposide—lung cancer	0.00203	0.00203	CcSEcCtD
Ceftizoxime—Anaemia—Gemcitabine—lung cancer	0.00203	0.00203	CcSEcCtD
Ceftizoxime—Leukopenia—Irinotecan—lung cancer	0.00202	0.00202	CcSEcCtD
Ceftizoxime—Paraesthesia—Vinorelbine—lung cancer	0.002	0.002	CcSEcCtD
Ceftizoxime—Erythema multiforme—Paclitaxel—lung cancer	0.00199	0.00199	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vinblastine—lung cancer	0.00198	0.00198	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00197	0.00197	CcSEcCtD
Ceftizoxime—Leukopenia—Gemcitabine—lung cancer	0.00196	0.00196	CcSEcCtD
Ceftizoxime—Hypersensitivity—Topotecan—lung cancer	0.00192	0.00192	CcSEcCtD
Ceftizoxime—Pain—Vinorelbine—lung cancer	0.00191	0.00191	CcSEcCtD
Ceftizoxime—Anaemia—Cisplatin—lung cancer	0.00189	0.00189	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—lung cancer	0.00187	0.00187	CcSEcCtD
Ceftizoxime—Agranulocytosis—Docetaxel—lung cancer	0.00186	0.00186	CcSEcCtD
Ceftizoxime—Pruritus—Topotecan—lung cancer	0.00184	0.00184	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Irinotecan—lung cancer	0.00184	0.00184	CcSEcCtD
Ceftizoxime—Diarrhoea—Vinblastine—lung cancer	0.00183	0.00183	CcSEcCtD
Ceftizoxime—Leukopenia—Cisplatin—lung cancer	0.00183	0.00183	CcSEcCtD
Ceftizoxime—Pruritus—Erlotinib—lung cancer	0.00182	0.00182	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Irinotecan—lung cancer	0.0018	0.0018	CcSEcCtD
Ceftizoxime—Haemoglobin—Docetaxel—lung cancer	0.0018	0.0018	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Gemcitabine—lung cancer	0.00179	0.00179	CcSEcCtD
Ceftizoxime—Haemorrhage—Docetaxel—lung cancer	0.00179	0.00179	CcSEcCtD
Ceftizoxime—Diarrhoea—Topotecan—lung cancer	0.00178	0.00178	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Docetaxel—lung cancer	0.00178	0.00178	CcSEcCtD
Ceftizoxime—Convulsion—Cisplatin—lung cancer	0.00177	0.00177	CcSEcCtD
Ceftizoxime—Diarrhoea—Erlotinib—lung cancer	0.00176	0.00176	CcSEcCtD
Ceftizoxime—Body temperature increased—Vinorelbine—lung cancer	0.00176	0.00176	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Gemcitabine—lung cancer	0.00175	0.00175	CcSEcCtD
Ceftizoxime—Anaemia—Etoposide—lung cancer	0.00173	0.00173	CcSEcCtD
Ceftizoxime—Vomiting—Vinblastine—lung cancer	0.0017	0.0017	CcSEcCtD
Ceftizoxime—Anaemia—Paclitaxel—lung cancer	0.0017	0.0017	CcSEcCtD
Ceftizoxime—Erythema multiforme—Docetaxel—lung cancer	0.00169	0.00169	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Leukopenia—Etoposide—lung cancer	0.00168	0.00168	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Cisplatin—lung cancer	0.00167	0.00167	CcSEcCtD
Ceftizoxime—Vomiting—Topotecan—lung cancer	0.00166	0.00166	CcSEcCtD
Ceftizoxime—Paraesthesia—Irinotecan—lung cancer	0.00165	0.00165	CcSEcCtD
Ceftizoxime—Leukopenia—Paclitaxel—lung cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Rash—Topotecan—lung cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vinorelbine—lung cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Dermatitis—Topotecan—lung cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Vomiting—Erlotinib—lung cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Cisplatin—lung cancer	0.00163	0.00163	CcSEcCtD
Ceftizoxime—Rash—Erlotinib—lung cancer	0.00163	0.00163	CcSEcCtD
Ceftizoxime—Dermatitis—Erlotinib—lung cancer	0.00162	0.00162	CcSEcCtD
Ceftizoxime—Convulsion—Etoposide—lung cancer	0.00162	0.00162	CcSEcCtD
Ceftizoxime—Paraesthesia—Gemcitabine—lung cancer	0.00161	0.00161	CcSEcCtD
Ceftizoxime—Eosinophilia—Methotrexate—lung cancer	0.00159	0.00159	CcSEcCtD
Ceftizoxime—Nausea—Vinblastine—lung cancer	0.00159	0.00159	CcSEcCtD
Ceftizoxime—Convulsion—Paclitaxel—lung cancer	0.00159	0.00159	CcSEcCtD
Ceftizoxime—Pruritus—Vinorelbine—lung cancer	0.00158	0.00158	CcSEcCtD
Ceftizoxime—Pain—Irinotecan—lung cancer	0.00157	0.00157	CcSEcCtD
Ceftizoxime—Nausea—Topotecan—lung cancer	0.00155	0.00155	CcSEcCtD
Ceftizoxime—Pain—Gemcitabine—lung cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Nausea—Erlotinib—lung cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Pancytopenia—Methotrexate—lung cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Etoposide—lung cancer	0.00153	0.00153	CcSEcCtD
Ceftizoxime—Diarrhoea—Vinorelbine—lung cancer	0.00152	0.00152	CcSEcCtD
Ceftizoxime—Neutropenia—Methotrexate—lung cancer	0.00151	0.00151	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Paclitaxel—lung cancer	0.0015	0.0015	CcSEcCtD
Ceftizoxime—Paraesthesia—Cisplatin—lung cancer	0.0015	0.0015	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Etoposide—lung cancer	0.0015	0.0015	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Paclitaxel—lung cancer	0.00147	0.00147	CcSEcCtD
Ceftizoxime—Body temperature increased—Irinotecan—lung cancer	0.00145	0.00145	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00145	0.00145	CcSEcCtD
Ceftizoxime—Anaemia—Docetaxel—lung cancer	0.00144	0.00144	CcSEcCtD
Ceftizoxime—Pain—Cisplatin—lung cancer	0.00143	0.00143	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00142	0.00142	CcSEcCtD
Ceftizoxime—Vomiting—Vinorelbine—lung cancer	0.00142	0.00142	CcSEcCtD
Ceftizoxime—Body temperature increased—Gemcitabine—lung cancer	0.00142	0.00142	CcSEcCtD
Ceftizoxime—Rash—Vinorelbine—lung cancer	0.00141	0.00141	CcSEcCtD
Ceftizoxime—Dermatitis—Vinorelbine—lung cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Leukopenia—Docetaxel—lung cancer	0.00139	0.00139	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—lung cancer	0.00138	0.00138	CcSEcCtD
Ceftizoxime—Paraesthesia—Etoposide—lung cancer	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Hypersensitivity—Irinotecan—lung cancer	0.00135	0.00135	CcSEcCtD
Ceftizoxime—Convulsion—Docetaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Ceftizoxime—Paraesthesia—Paclitaxel—lung cancer	0.00135	0.00135	CcSEcCtD
Ceftizoxime—Agranulocytosis—Methotrexate—lung cancer	0.00134	0.00134	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—lung cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Nausea—Vinorelbine—lung cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Body temperature increased—Cisplatin—lung cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Pain—Etoposide—lung cancer	0.00131	0.00131	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—lung cancer	0.0013	0.0013	CcSEcCtD
Ceftizoxime—Haemoglobin—Methotrexate—lung cancer	0.0013	0.0013	CcSEcCtD
Ceftizoxime—Haemorrhage—Methotrexate—lung cancer	0.00129	0.00129	CcSEcCtD
Ceftizoxime—Pain—Paclitaxel—lung cancer	0.00128	0.00128	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Docetaxel—lung cancer	0.00127	0.00127	CcSEcCtD
Ceftizoxime—Pruritus—Gemcitabine—lung cancer	0.00127	0.00127	CcSEcCtD
Ceftizoxime—Diarrhoea—Irinotecan—lung cancer	0.00126	0.00126	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Docetaxel—lung cancer	0.00124	0.00124	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00123	0.00123	CcSEcCtD
Ceftizoxime—Hypersensitivity—Cisplatin—lung cancer	0.00123	0.00123	CcSEcCtD
Ceftizoxime—Diarrhoea—Gemcitabine—lung cancer	0.00122	0.00122	CcSEcCtD
Ceftizoxime—Erythema multiforme—Methotrexate—lung cancer	0.00122	0.00122	CcSEcCtD
Ceftizoxime—Body temperature increased—Etoposide—lung cancer	0.00121	0.00121	CcSEcCtD
Ceftizoxime—Body temperature increased—Paclitaxel—lung cancer	0.00118	0.00118	CcSEcCtD
Ceftizoxime—Vomiting—Irinotecan—lung cancer	0.00117	0.00117	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—lung cancer	0.00116	0.00116	CcSEcCtD
Ceftizoxime—Rash—Irinotecan—lung cancer	0.00116	0.00116	CcSEcCtD
Ceftizoxime—Dermatitis—Irinotecan—lung cancer	0.00116	0.00116	CcSEcCtD
Ceftizoxime—Diarrhoea—Cisplatin—lung cancer	0.00114	0.00114	CcSEcCtD
Ceftizoxime—Paraesthesia—Docetaxel—lung cancer	0.00114	0.00114	CcSEcCtD
Ceftizoxime—Vomiting—Gemcitabine—lung cancer	0.00114	0.00114	CcSEcCtD
Ceftizoxime—Rash—Gemcitabine—lung cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Dermatitis—Gemcitabine—lung cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Hypersensitivity—Etoposide—lung cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—lung cancer	0.00112	0.00112	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—lung cancer	0.00112	0.00112	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—lung cancer	0.00111	0.00111	CcSEcCtD
Ceftizoxime—Hypersensitivity—Paclitaxel—lung cancer	0.0011	0.0011	CcSEcCtD
Ceftizoxime—Nausea—Irinotecan—lung cancer	0.00109	0.00109	CcSEcCtD
Ceftizoxime—Pain—Docetaxel—lung cancer	0.00109	0.00109	CcSEcCtD
Ceftizoxime—Pruritus—Etoposide—lung cancer	0.00108	0.00108	CcSEcCtD
Ceftizoxime—Nausea—Gemcitabine—lung cancer	0.00106	0.00106	CcSEcCtD
Ceftizoxime—Vomiting—Cisplatin—lung cancer	0.00106	0.00106	CcSEcCtD
Ceftizoxime—Pruritus—Paclitaxel—lung cancer	0.00106	0.00106	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—lung cancer	0.00106	0.00106	CcSEcCtD
Ceftizoxime—Rash—Cisplatin—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Dermatitis—Cisplatin—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Diarrhoea—Etoposide—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Anaemia—Methotrexate—lung cancer	0.00104	0.00104	CcSEcCtD
Ceftizoxime—Diarrhoea—Paclitaxel—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftizoxime—Body temperature increased—Docetaxel—lung cancer	0.001	0.001	CcSEcCtD
Ceftizoxime—Leukopenia—Methotrexate—lung cancer	0.001	0.001	CcSEcCtD
Ceftizoxime—Nausea—Cisplatin—lung cancer	0.000991	0.000991	CcSEcCtD
Ceftizoxime—Convulsion—Methotrexate—lung cancer	0.000972	0.000972	CcSEcCtD
Ceftizoxime—Vomiting—Etoposide—lung cancer	0.000972	0.000972	CcSEcCtD
Ceftizoxime—Rash—Etoposide—lung cancer	0.000964	0.000964	CcSEcCtD
Ceftizoxime—Dermatitis—Etoposide—lung cancer	0.000963	0.000963	CcSEcCtD
Ceftizoxime—Vomiting—Paclitaxel—lung cancer	0.000953	0.000953	CcSEcCtD
Ceftizoxime—Rash—Paclitaxel—lung cancer	0.000945	0.000945	CcSEcCtD
Ceftizoxime—Dermatitis—Paclitaxel—lung cancer	0.000944	0.000944	CcSEcCtD
Ceftizoxime—Hypersensitivity—Docetaxel—lung cancer	0.000936	0.000936	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Methotrexate—lung cancer	0.000916	0.000916	CcSEcCtD
Ceftizoxime—Nausea—Etoposide—lung cancer	0.000908	0.000908	CcSEcCtD
Ceftizoxime—Pruritus—Docetaxel—lung cancer	0.000899	0.000899	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—lung cancer	0.000898	0.000898	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Methotrexate—lung cancer	0.000897	0.000897	CcSEcCtD
Ceftizoxime—Nausea—Paclitaxel—lung cancer	0.00089	0.00089	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—lung cancer	0.00087	0.00087	CcSEcCtD
Ceftizoxime—Diarrhoea—Docetaxel—lung cancer	0.000869	0.000869	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—lung cancer	0.000842	0.000842	CcSEcCtD
Ceftizoxime—Paraesthesia—Methotrexate—lung cancer	0.000822	0.000822	CcSEcCtD
Ceftizoxime—Vomiting—Docetaxel—lung cancer	0.000808	0.000808	CcSEcCtD
Ceftizoxime—Rash—Docetaxel—lung cancer	0.000801	0.000801	CcSEcCtD
Ceftizoxime—Dermatitis—Docetaxel—lung cancer	0.0008	0.0008	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—lung cancer	0.000793	0.000793	CcSEcCtD
Ceftizoxime—Pain—Methotrexate—lung cancer	0.000783	0.000783	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—lung cancer	0.000776	0.000776	CcSEcCtD
Ceftizoxime—Nausea—Docetaxel—lung cancer	0.000755	0.000755	CcSEcCtD
Ceftizoxime—Body temperature increased—Methotrexate—lung cancer	0.000724	0.000724	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—lung cancer	0.000712	0.000712	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—lung cancer	0.000678	0.000678	CcSEcCtD
Ceftizoxime—Hypersensitivity—Methotrexate—lung cancer	0.000675	0.000675	CcSEcCtD
Ceftizoxime—Pruritus—Methotrexate—lung cancer	0.000648	0.000648	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—lung cancer	0.000627	0.000627	CcSEcCtD
Ceftizoxime—Diarrhoea—Methotrexate—lung cancer	0.000627	0.000627	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—lung cancer	0.000584	0.000584	CcSEcCtD
Ceftizoxime—Vomiting—Methotrexate—lung cancer	0.000582	0.000582	CcSEcCtD
Ceftizoxime—Rash—Methotrexate—lung cancer	0.000577	0.000577	CcSEcCtD
Ceftizoxime—Dermatitis—Methotrexate—lung cancer	0.000577	0.000577	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—lung cancer	0.000561	0.000561	CcSEcCtD
Ceftizoxime—Nausea—Methotrexate—lung cancer	0.000544	0.000544	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—lung cancer	0.000543	0.000543	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—lung cancer	0.000504	0.000504	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—lung cancer	0.0005	0.0005	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—lung cancer	0.000499	0.000499	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—lung cancer	0.000471	0.000471	CcSEcCtD
